Protagonist Therapeutics, Inc (PTGX) Operating margin 2017–2025
Protagonist Therapeutics, Inc (PTGX) operating margin by fiscal year — reported operating income divided by reported revenue.
-343.6%FY2025 · since FY2017: -188.9% → -343.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -343.6% | -401.8 pp |
| FY2024 | 58.2% | +214.3 pp |
| FY2023 | -156.1% | +338.1 pp |
| FY2022 | -494.2% | -34.2 pp |
| FY2021 | -460.0% | -234.7 pp |
| FY2020 | -225.4% | +34632.2 pp |
| FY2019 | -34857.6% | -34720.9 pp |
| FY2018 | -136.7% | +52.2 pp |
| FY2017 | -188.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice